Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitinationRuhi Polara, Briony L Gliddon, Raja Ganesan, et al.
Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.
Human Mutation|June 3, 2021
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variantsDuyen H Pham, Melissa R Pitman, Raman Kumar, et al.
Clinical & Translational Immunology|October 21, 2020
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapyLisa M Ebert, Wenbo Yu, Tessa Gargett, et al.
Nature Medicine|July 28, 2014
Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidationDaisuke Yamane, David R McGivern, Eliane Wauthier, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Cancer Cell|June 9, 2023
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemiaVanessa M Conn, Marta Gabryelska, John Toubia, et al.
Blood|August 18, 2023
Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCsShruthi Subramanian, Julie A I Thoms, Yizhou Huang, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Blood|March 12, 2017
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell populationNadine Hein, Donald P Cameron, Katherine M Hannan, et al.
Pageof 14